tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lavin, 92 are a BUY (80%), 23 are a HOLD (20%).
Analyst Sean Lavin, currently employed at BTIG, carries an average stock price target met ratio of 85.38% that have a potential upside of 29.81% achieved within 276 days.
Sean Lavin’s has documented 207 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MASI, Masimo at 26-Feb-2025.
Analyst best performing recommendations are on TRXC (ASENSUS SURGICAL).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 11/14/2016. The price target of $28 was fulfilled within 4 days with a profit of $3.18 (12.81%) receiving and performance score of 32.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Nov-2022
$388
$6.98 (1.83%)
$355
3 years 4 months 18 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold Since 02-Nov-2022
$380
$-1.02 (-0.27%)
$235
3 years 4 months 18 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold Since 01-Nov-2022
$380
$-1.02 (-0.27%)
$350
3 years 4 months 19 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy Since 30-Jun-2021
$300
$-81.02 (-21.26%)
$425
3 years 5 months 8 days ago
(12-Oct-2022)
1/2 (50%)
$57.23 (23.57%)
20
Sell Since 11-Feb-2020
$235
$-146.02 (-38.32%)
$275
3 years 8 months 5 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
What Year was the first public recommendation made by Sean Lavin?
